未登录

A

Alessandro Corsaro

University of Genova

H指数:34

被引数:2,876

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Repurposing Triamterene as Chloride Intracellular Channel 1 Inhibitor via Ligand-Based Approach: A Novel Adjuvant Treatment for Glioblastoma

通过基于配体方法重新利用氨苯蝶啶作为氯离子通道1抑制剂：胶质母细胞瘤的新型辅助治疗方法

Molecular Therapy

IF12

2026-07-180

OAAI

Microglia Reprogramming in Glioblastoma: Stem Cell-Derived Factors as Emerging Immunomodulators

胶质母细胞瘤中的小胶质细胞重编程：干细胞衍生物作为新兴的免疫调节因子

IF5.2

2026-05-040

OAAI

Simple and Rapid Model to Generate Differentiated Endometrial Floating Organoids

简单快速模型以生成分化子宫内膜悬浮类器官

IF1.1

2026-02-050

PRE

Drug enteric metabolism in gut microbiota-brain crosstalk

肠道微生物-脑轴相互作用中的药物肠内代谢

IF5.1

2025-11-070

PRE

A FLOATING ENDOMETRIAL ORGANOID MODEL RECAPITULATES EPITHELIAL-STROMAL CELL INTERACTIONS IN VITRO,

一种浮动的子宫内膜类器官模型在体外重现了上皮-间质细胞相互作用，

Experimental Cell Research

IF3.5

2025-09-080

OAAI

The expression of pro-prion, a transmembrane isoform of the prion protein, leads to the constitutive activation of the canonical Wnt/β-catenin pathway to sustain the stem-like phenotype of human glioblastoma cells

CANCER CELL INTERNATIONAL

IF6

2024-12-230

OAAI

Human glioblastoma-derived cell membrane nanovesicles: a novel, cell-specific strategy for boron neutron capture therapy of brain tumors

SCIENTIFIC REPORTS

IF3.9

2024-08-205

OAAI

Antitumor Potential of Antiepileptic Drugs in Human Glioblastoma: Pharmacological Targets and Clinical Benefits

抗癫痫药在人类胶质母细胞瘤中的抗肿瘤潜力: 药理靶标和临床益处

IF3.9

2023-02-1611

OAAI

Proteostasis unbalance in prion diseases: Mechanisms of neurodegeneration and therapeutic targets

FRONTIERS IN NEUROSCIENCE

IF3.2

2022-09-0610

OAAI

Experimental Evidence and Clinical Implications of Pituitary Adenoma Stem Cells

FRONTIERS IN ENDOCRINOLOGY

IF4.6

2020-02-2018

OAAI

Emerging Role of Cellular Prion Protein in the Maintenance and Expansion of Glioma Stem Cells

IF5.2

2019-11-1815

OAAI

Pharmacological activation of autophagy favors the clearing of intracellular aggregates of misfolded prion protein peptide to prevent neuronal death

CELL DEATH & DISEASE

IF9.6

2018-02-0743

OAAI

In vitro and in vivo characterization of stem-like cells from canine osteosarcoma and assessment of drug sensitivity

EXPERIMENTAL CELL RESEARCH

IF3.5

2018-02-0129

OAAI

Different Effects of Human Umbilical Cord Mesenchymal Stem Cells on Glioblastoma Stem Cells by Direct Cell Interaction or Via Released Soluble Factors

FRONTIERS IN CELLULAR NEUROSCIENCE

IF4

2017-10-1359

OAAI

A critical concentration of N-terminal pyroglutamylated amyloid beta drives the misfolding of Ab1-42 into more toxic aggregates

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

IF2.8

2016-10-0144

PREAI

Cabergoline modulation of α-subunits and FSH secretion in a gonadotroph adenoma

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION

IF3.5

2014-03-1113

PREAI

Prolonged treatment with α-glycerylphosphoryl-ethanolamine facilitates the acquisition of an active avoidance behavior and selectively increases neuronal signal transduction in rats

aging clinical and experimental research

IF0

2014-01-075

PRE

Metformin selectively affects human glioblastoma tumor-initiating cell viability A role for metformin-induced inhibition of Akt

IF3.4

2012-12-19167

OA

Differential toxicity, conformation and morphology of typical initial aggregation states of Aβ1-42 and Aβpy3-42 beta-amyloids

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

IF2.8

2012-11-0152

PRE

Human PrP90-231-induced cell death is associated with intracellular accumulation of insoluble and protease-resistant macroaggregates and lysosomal dysfunction

CELL DEATH & DISEASE

IF9.6

2011-03-3132

OAAI